Our expert contributors
Michael Bush is the CEO of prebiotic manufacturer Prenexus health. Previously Michael was the president and CEO of the leading probiotic manufacturer, Ganeden, which was sold to Kerry in 2017. Michael is also a board member for several for and not-for-profit organizations, including Executive Board Member of the International Probiotics Association (IPA).
Shane Durkee is the vice president of platform innovation, ingredients, and dosage form solutions at Lonza. An internationally trained R&D executive with more than 25 years of experience in the consumer healthcare industry, Shane has a background of developing new and innovative products, platform capabilities and technologies.
Samantha Ford is a clinical nutritionist and has a master’s in applied nutrition from Northeastern University. She has worked with companies including ProCaps Laboratories and Amway. Currently, as director of business development at AIDP, she works collaboratively with industry partners and businesses across the wider health and nutrition business.
Florian Isermeyer is the venture lead gut comfort for the OneHealth division of Novozymes. Florian has been engaged in New Business Development activities with Novozymes since 2011. He is currently focusing on Human Health and building a venture for Novozymes around remedies to food sensitivities (lactose, gluten, etc.). He comes with an education from Stockholm School of Economics and the University of St. Gallen.
A recognized industry analyst and thought leader, Len Monheit has over 20 years of experience in the natural products and dietary supplement industry, with over 15 years background in digital media. He was the founder of NPIcenter; served in multiple roles with New Hope Natural Media, including executive director of strategic business development; and was general manager, US, for William Reed. In addition to his role with GPA, he is also CEO of Trust Transparency Research.
Stef Vanquickenborne currently serves as vice president R&D, capsules and health ingredients with Lonza, bringing expertise from his long tenure at Capsugel when it was acquired by Lonza. He has worked in VP, senior director and project development positions related to capsules and systems projects, and is also a software development engineer.